Caxton Corp as of Sept. 30, 2024
Portfolio Holdings for Caxton Corp
Caxton Corp holds 12 positions in its portfolio as reported in the September 2024 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Xeris Pharmaceuticals (XERS) | 60.3 | $15M | 5.1M | 2.85 | |
| Rezolute Com New (RZLT) | 26.5 | $6.4M | 1.3M | 4.85 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 6.8 | $1.6M | 2.9k | 573.74 | |
| Berkshire Hathaway Inc Del Cl B New (BRK.B) | 2.2 | $530k | 1.2k | 460.10 | |
| Bicara Therapeutics (BCAX) | 1.2 | $279k | 11k | 25.47 | |
| Mind Medicine Mindmed Com New (MNMD) | 0.8 | $194k | 34k | 5.69 | |
| Lexeo Therapeutics (LXEO) | 0.7 | $161k | 18k | 9.04 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.5 | $131k | 11k | 11.52 | |
| Kyverna Therapeutics (KYTX) | 0.5 | $112k | 23k | 4.89 | |
| Compass Therapeutics (CMPX) | 0.3 | $80k | 44k | 1.84 | |
| Context Therapeutics (CNTX) | 0.1 | $36k | 18k | 1.96 | |
| Adicet Bio (ACET) | 0.1 | $25k | 18k | 1.44 |
